All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
05/23/17	UPLOAD	SEC-generated letter	1
05/15/17	S-1	General form of registration statement for all companies including face-amount certificate companies Documents EX-5.1 EX-23.1	38
05/15/17	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	78
04/26/17	8-K	Current report filing Documents EX-99.1	4
04/25/17	DEF 14A	Definitive proxy statements	39
04/21/17	8-K	Current report filing Documents EX-10.1 EX-10.2 EX-99.1	34
03/20/17	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5.1 EX-23.2	7
03/20/17	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-10.12 EX-10.13 EX-21.1 EX-23.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	179
02/14/17	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	4
02/14/17	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	14